ANIP | | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP & CFO | Mar 23, 2024 | Option Exercise | $69.58 | 6,210 | 432,092 | 171,502 | Mar 25, 2024, 04:17 PM |
ANIP | | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS & PROD DEV | Mar 23, 2024 | Option Exercise | $69.58 | 3,653 | 254,176 | 118,805 | Mar 25, 2024, 04:14 PM |
ANIP | | ANI PHARMACEUTICALS INC | Lalwani Nikhil | PRESIDENT & CEO | Mar 23, 2024 | Option Exercise | $69.58 | 17,455 | 1,214,519 | 394,174 | Mar 25, 2024, 04:09 PM |
ANIP | | ANI PHARMACEUTICALS INC | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Mar 13, 2024 | Sale | $66.54 | 250 | 16,635 | 59,981 | Mar 13, 2024, 04:48 PM |
ANIP | | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Mar 11, 2024 | Sale | $65.81 | 20,000 | 1,316,200 | 273,226 | Mar 13, 2024, 04:44 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Mar 08, 2024 | Sale | $67.17 | 10,000 | 671,700 | 832,620 | Mar 11, 2024, 06:43 PM |
ANIP | | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP & CFO | Mar 11, 2024 | Sale | $65.55 | 7,787 | 510,438 | 177,712 | Mar 11, 2024, 06:39 PM |
ANIP | | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP & CFO | Mar 07, 2024 | Option Exercise | $66.71 | 4,216 | 281,249 | 185,499 | Mar 11, 2024, 06:39 PM |
ANIP | | ANI PHARMACEUTICALS INC | Lalwani Nikhil | PRESIDENT & CEO | Mar 06, 2024 | Sale | $65.52 | 28,965 | 1,897,787 | 444,981 | Mar 08, 2024, 07:25 PM |
ANIP | | ANI PHARMACEUTICALS INC | Lalwani Nikhil | PRESIDENT & CEO | Mar 07, 2024 | Option Exercise | $66.71 | 17,060 | 1,138,073 | 427,921 | Mar 08, 2024, 07:25 PM |
ANIP | | ANI PHARMACEUTICALS INC | Lalwani Nikhil | PRESIDENT & CEO | Mar 08, 2024 | Sale | $67.13 | 16,292 | 1,093,682 | 411,629 | Mar 08, 2024, 07:25 PM |
ANIP | | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS & PROD DEV | Mar 07, 2024 | Option Exercise | $66.40 | 26,372 | 1,751,001 | 124,492 | Mar 07, 2024, 09:42 PM |
ANIP | | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | Mar 07, 2024 | Option Exercise | $66.71 | 2,494 | 166,375 | 80,212 | Mar 07, 2024, 09:21 PM |
ANIP | | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | Mar 07, 2024 | Option Exercise | $66.71 | 2,110 | 140,758 | 85,277 | Mar 07, 2024, 09:16 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Mar 05, 2024 | Sale | $65.35 | 10,093 | 659,578 | 872,527 | Mar 07, 2024, 09:11 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Mar 06, 2024 | Sale | $65.47 | 14,822 | 970,396 | 857,705 | Mar 07, 2024, 09:11 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Mar 07, 2024 | Sale | $66.35 | 15,085 | 1,000,890 | 842,620 | Mar 07, 2024, 09:11 PM |
ANIP | | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | Mar 05, 2024 | Sale | $66.00 | 5,000 | 330,000 | 87,387 | Mar 06, 2024, 04:24 PM |
ANIP | | ANI PHARMACEUTICALS INC | Pera Antonio R | Director | Mar 04, 2024 | Sale | $65.20 | 7,000 | 456,400 | 26,627 | Mar 06, 2024, 04:20 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Feb 29, 2024 | Option Exercise | $67.67 | 1,122 | 75,926 | 68,652 | Mar 01, 2024, 05:18 PM |
ANIP | | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | Feb 29, 2024 | Option Exercise | $67.67 | 1,275 | 86,279 | 92,387 | Mar 01, 2024, 05:12 PM |
ANIP | | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS & PROD DEV | Feb 29, 2024 | Option Exercise | $67.67 | 1,058 | 71,595 | 148,830 | Mar 01, 2024, 05:09 PM |
ANIP | | ANI PHARMACEUTICALS INC | Lalwani Nikhil | PRESIDENT & CEO | Feb 29, 2024 | Option Exercise | $67.67 | 10,014 | 677,647 | 473,946 | Mar 01, 2024, 05:06 PM |
ANIP | | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | Feb 29, 2024 | Option Exercise | $67.67 | 1,570 | 106,242 | 82,706 | Mar 01, 2024, 05:03 PM |
ANIP | | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Feb 29, 2024 | Option Exercise | $67.67 | 1,635 | 110,640 | 49,679 | Mar 01, 2024, 05:01 PM |
ANIP | | ANI PHARMACEUTICALS INC | Davis Krista | SVP, CHIEF HR OFFICER | Feb 29, 2024 | Option Exercise | $67.67 | 1,173 | 79,377 | 51,545 | Mar 01, 2024, 04:59 PM |
ANIP | | ANI PHARMACEUTICALS INC | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Feb 29, 2024 | Option Exercise | $67.67 | 1,173 | 79,377 | 60,231 | Mar 01, 2024, 04:57 PM |
ANIP | | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP & CFO | Feb 29, 2024 | Option Exercise | $67.67 | 1,914 | 129,520 | 189,715 | Mar 01, 2024, 04:55 PM |
ANIP | | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | Feb 15, 2024 | Option Exercise | $57.55 | 1,244 | 71,592 | 84,276 | Feb 20, 2024, 05:09 PM |
ANIP | | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | Feb 15, 2024 | Option Exercise | $57.55 | 1,261 | 72,571 | 93,662 | Feb 20, 2024, 05:02 PM |
ANIP | | ANI PHARMACEUTICALS INC | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Feb 13, 2024 | Sale | $56.04 | 250 | 14,010 | 36,799 | Feb 13, 2024, 08:05 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jan 22, 2024 | Sale | $55.95 | 5,692 | 318,467 | 897,620 | Jan 23, 2024, 05:32 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jan 23, 2024 | Sale | $56.44 | 15,000 | 846,600 | 882,620 | Jan 23, 2024, 05:32 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jan 19, 2024 | Sale | $55.57 | 4,524 | 251,399 | 903,312 | Jan 23, 2024, 05:32 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jan 16, 2024 | Sale | $55.63 | 5,000 | 278,150 | 927,620 | Jan 18, 2024, 06:20 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jan 17, 2024 | Sale | $55.11 | 10,000 | 551,100 | 917,620 | Jan 18, 2024, 06:20 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jan 18, 2024 | Sale | $55.30 | 9,784 | 541,055 | 907,836 | Jan 18, 2024, 06:20 PM |
ANIP | | ANI PHARMACEUTICALS INC | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Jan 12, 2024 | Sale | $56.43 | 250 | 14,108 | 37,049 | Jan 16, 2024, 09:09 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Dec 15, 2023 | Sale | $52.44 | 11,974 | 627,917 | 970,646 | Dec 19, 2023, 05:44 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Dec 18, 2023 | Sale | $52.44 | 13,026 | 683,083 | 957,620 | Dec 19, 2023, 05:44 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Dec 19, 2023 | Sale | $52.65 | 25,000 | 1,316,250 | 932,620 | Dec 19, 2023, 05:44 PM |
ANIP | | ANI PHARMACEUTICALS INC | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Dec 11, 2023 | Sale | $49.21 | 250 | 12,302 | 37,299 | Dec 11, 2023, 05:49 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Nov 17, 2023 | Sale | $51.00 | 13,000 | 663,000 | 982,620 | Nov 20, 2023, 09:05 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Nov 16, 2023 | Sale | $51.66 | 6,448 | 333,104 | 995,620 | Nov 20, 2023, 08:58 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Nov 14, 2023 | Sale | $53.17 | 22,905 | 1,217,859 | 1,009,715 | Nov 20, 2023, 08:58 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Nov 15, 2023 | Sale | $53.64 | 7,647 | 410,185 | 1,002,068 | Nov 20, 2023, 08:58 PM |
ANIP | | ANI PHARMACEUTICALS INC | Davis Krista | SVP, CHIEF HR OFFICER | Nov 15, 2023 | Sale | $53.81 | 2,622 | 141,090 | 32,587 | Nov 16, 2023, 06:13 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Nov 15, 2023 | Sale | $53.64 | 7,647 | 410,185 | 1,002,878 | Nov 16, 2023, 06:11 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Nov 16, 2023 | Sale | $51.66 | 6,448 | 333,104 | 996,430 | Nov 16, 2023, 06:11 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Nov 14, 2023 | Sale | $53.17 | 22,095 | 1,174,791 | 1,010,525 | Nov 16, 2023, 06:11 PM |
ANIP | | ANI PHARMACEUTICALS INC | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Nov 13, 2023 | Sale | $52.03 | 250 | 13,007 | 37,549 | Nov 14, 2023, 05:04 PM |
ANIP | | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | Nov 10, 2023 | Sale | $52.47 | 3,000 | 157,410 | 63,607 | Nov 13, 2023, 04:02 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Oct 18, 2023 | Sale | $57.78 | 6,242 | 360,663 | 1,042,620 | Oct 19, 2023, 04:28 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Oct 19, 2023 | Sale | $57.06 | 10,000 | 570,600 | 1,032,620 | Oct 19, 2023, 04:28 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Oct 17, 2023 | Sale | $58.53 | 8,758 | 512,606 | 1,048,862 | Oct 19, 2023, 04:28 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Oct 13, 2023 | Sale | $57.58 | 11,937 | 687,332 | 1,070,683 | Oct 17, 2023, 04:32 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Oct 16, 2023 | Sale | $58.31 | 13,063 | 761,704 | 1,057,620 | Oct 17, 2023, 04:32 PM |
ANIP | | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Oct 02, 2023 | Sale | $56.48 | 20,000 | 1,129,600 | 293,226 | Oct 03, 2023, 08:00 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Sep 18, 2023 | Sale | $61.64 | 8,425 | 519,317 | 1,107,953 | Sep 19, 2023, 05:14 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Sep 19, 2023 | Sale | $61.23 | 25,333 | 1,551,140 | 1,082,620 | Sep 19, 2023, 05:14 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Sep 15, 2023 | Sale | $62.81 | 16,242 | 1,020,160 | 1,116,378 | Sep 19, 2023, 05:14 PM |
ANIP | | ANI PHARMACEUTICALS INC | Davis Krista | SVP, CHIEF HR OFFICER | Sep 12, 2023 | Option Exercise | $61.91 | 1,486 | 91,998 | 35,209 | Sep 14, 2023, 08:01 AM |
ANIP | | ANI PHARMACEUTICALS INC | Lalwani Nikhil | PRESIDENT & CEO | Sep 08, 2023 | Option Exercise | $61.94 | 3,646 | 225,833 | 349,744 | Sep 11, 2023, 06:23 PM |
ANIP | | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Sep 01, 2023 | Sale | $64.70 | 20,000 | 1,294,000 | 313,226 | Sep 05, 2023, 05:06 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Aug 29, 2023 | Sale | $63.37 | 25,000 | 1,584,250 | 1,132,620 | Aug 30, 2023, 04:29 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Aug 28, 2023 | Sale | $63.06 | 25,000 | 1,576,500 | 1,157,620 | Aug 30, 2023, 04:29 PM |
ANIP | | ANI PHARMACEUTICALS INC | Gutwerg Ori | SVP, GENERICS | Aug 23, 2023 | Sale | $48.03 | 29,063 | 1,396,029 | 76,476 | Aug 25, 2023, 04:22 PM |
ANIP | | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS & PROD DEV | Aug 23, 2023 | Sale | $48.66 | 9,349 | 454,940 | 137,044 | Aug 25, 2023, 04:17 PM |
ANIP | | ANI PHARMACEUTICALS INC | Meridian Venture Partners II, Co. | 10% Owner | Aug 16, 2023 | Sale | $58.50 | 200,000 | 11,700,000 | 1,819,259 | Aug 16, 2023, 08:00 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Aug 15, 2023 | Sale | $61.60 | 22,110 | 1,361,976 | 1,182,620 | Aug 16, 2023, 07:07 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Aug 14, 2023 | Sale | $61.15 | 27,890 | 1,705,474 | 1,204,730 | Aug 16, 2023, 07:07 PM |
ANIP | | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP & CFO | Aug 14, 2023 | Sale | $61.37 | 17,639 | 1,082,505 | 155,839 | Aug 16, 2023, 04:24 PM |
ANIP | | ANI PHARMACEUTICALS INC | Pera Antonio R | Director | Aug 14, 2023 | Sale | $60.37 | 3,000 | 181,110 | 33,627 | Aug 15, 2023, 08:45 PM |
ANIP | | ANI PHARMACEUTICALS INC | Lalwani Nikhil | PRESIDENT & CEO | Aug 11, 2023 | Sale | $57.75 | 56,666 | 3,272,462 | 353,390 | Aug 15, 2023, 08:39 PM |
ANIP | | ANI PHARMACEUTICALS INC | Lalwani Nikhil | PRESIDENT & CEO | Aug 15, 2023 | Sale | $45.07 | 23,232 | 1,046,950 | 365,006 | Aug 15, 2023, 08:39 PM |
ANIP | | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Aug 01, 2023 | Sale | $51.06 | 20,000 | 1,021,200 | 333,226 | Aug 03, 2023, 06:03 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jul 19, 2023 | Sale | $51.48 | 5,969 | 307,284 | 1,250,120 | Jul 21, 2023, 07:15 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jul 20, 2023 | Sale | $51.52 | 6,000 | 309,120 | 1,244,120 | Jul 21, 2023, 07:15 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jul 21, 2023 | Sale | $52.56 | 11,500 | 604,440 | 1,232,620 | Jul 21, 2023, 07:15 PM |
ANIP | | ANI PHARMACEUTICALS INC | Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | Jul 18, 2023 | Option Exercise | $51.89 | 1,743 | 90,444 | 37,799 | Jul 19, 2023, 07:14 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jul 14, 2023 | Sale | $50.43 | 10,000 | 504,300 | 1,272,620 | Jul 18, 2023, 08:06 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jul 17, 2023 | Sale | $51.06 | 9,831 | 501,971 | 1,262,789 | Jul 18, 2023, 08:06 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jul 18, 2023 | Sale | $51.84 | 6,700 | 347,328 | 1,256,089 | Jul 18, 2023, 08:06 PM |
ANIP | | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Jul 03, 2023 | Sale | $53.43 | 20,000 | 1,068,600 | 353,226 | Jul 06, 2023, 04:15 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jun 23, 2023 | Sale | $51.49 | 10,000 | 514,900 | 1,282,620 | Jun 23, 2023, 08:01 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jun 20, 2023 | Sale | $51.93 | 14,657 | 761,138 | 1,317,963 | Jun 23, 2023, 08:01 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jun 21, 2023 | Sale | $51.95 | 11,843 | 615,244 | 1,306,120 | Jun 23, 2023, 08:01 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jun 22, 2023 | Sale | $51.38 | 13,500 | 693,630 | 1,292,620 | Jun 23, 2023, 08:01 PM |
ANIP | | ANI PHARMACEUTICALS INC | Gassert Chad | SVP - CORP. DEV. & STRATEGY | Jun 22, 2023 | Sale | $51.32 | 20,000 | 1,026,400 | 373,226 | Jun 23, 2023, 08:00 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jun 21, 2023 | Sale | $51.95 | 11,843 | 615,244 | 20,907 | Jun 22, 2023, 08:00 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jun 22, 2023 | Sale | $51.38 | 13,500 | 693,630 | 7,407 | Jun 22, 2023, 08:00 PM |
ANIP | | ANI PHARMACEUTICALS INC | Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | Jun 20, 2023 | Sale | $51.93 | 14,657 | 761,138 | 32,750 | Jun 22, 2023, 08:00 PM |
ANIP | | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP & CFO | Apr 10, 2023 | Option Exercise | $38.50 | 4,534 | 174,559 | 173,478 | Apr 12, 2023, 04:43 PM |
ANIP | | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS & PROD DEV | Apr 10, 2023 | Option Exercise | $38.50 | 2,289 | 88,127 | 131,627 | Apr 12, 2023, 04:42 PM |
ANIP | | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS & PROD DEV | Mar 28, 2023 | Option Exercise | $38.62 | 524 | 20,237 | 112,206 | Mar 30, 2023, 08:01 PM |
ANIP | | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP AND CFO | Mar 28, 2023 | Option Exercise | $38.62 | 1,420 | 54,840 | 137,486 | Mar 30, 2023, 08:00 PM |
ANIP | | ANI PHARMACEUTICALS INC | Marken James G. | SVP OPS & PROD DEV | Mar 23, 2023 | Option Exercise | $37.82 | 2,452 | 92,735 | 112,730 | Mar 27, 2023, 08:02 PM |
ANIP | | ANI PHARMACEUTICALS INC | Lalwani Nikhil | PRESIDENT & CEO | Mar 23, 2023 | Option Exercise | $37.82 | 17,455 | 660,148 | 250,840 | Mar 27, 2023, 08:01 PM |
ANIP | | ANI PHARMACEUTICALS INC | CAREY STEPHEN P. | SVP AND CFO | Mar 23, 2023 | Option Exercise | $37.82 | 4,224 | 159,752 | 138,906 | Mar 27, 2023, 08:00 PM |
ANIP | | ANI PHARMACEUTICALS INC | Mutz Christopher | HEAD OF RARE DISEASE | Mar 07, 2023 | Option Exercise | $44.23 | 1,902 | 84,125 | 38,136 | Mar 09, 2023, 06:48 PM |